{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:48:17Z","timestamp":1790257697815,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Aerospace Medical Research Projects","award":["2022YK08"],"award-info":[{"award-number":["2022YK08"]}]},{"name":"Key Research Project of Hunan Aerospace Hospital","award":["2022YJ03"],"award-info":[{"award-number":["2022YJ03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13770-024-00631-7","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T13:03:06Z","timestamp":1712149386000},"page":"609-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles on Inhibition of Hepatic Fibrosis by Delivering miR-200a"],"prefix":"10.1007","volume":"21","author":[{"given":"Ai-Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1055-3035","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"631_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75:473\u201388.","journal-title":"Hepatology"},{"key":"631_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/jir.2020.0059","volume":"40","author":"RM Dawood","year":"2020","unstructured":"Dawood RM, El-Meguid MA, Salum GM, El Awady MK. Key players of hepatic fibrosis. J Interferon Cytokine Res. 2020;40:472\u201389.","journal-title":"J Interferon Cytokine Res"},{"key":"631_CR3","doi-asserted-by":"publisher","first-page":"105765","DOI":"10.1016\/j.intimp.2019.105765","volume":"75","author":"L Shan","year":"2019","unstructured":"Shan L, Liu Z, Ci L, Shuai C, Lv X, Li J. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. Int Immunopharmacol. 2019;75:105765.","journal-title":"Int Immunopharmacol"},{"key":"631_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018;93:19\u201331.","journal-title":"Cytometry A"},{"key":"631_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9:63.","journal-title":"Stem Cell Res Ther"},{"key":"631_CR6","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1038\/emm.2017.63","volume":"49","author":"G Lou","year":"2017","unstructured":"Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49:e346.","journal-title":"Exp Mol Med"},{"key":"631_CR7","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.3390\/ijms222413292","volume":"22","author":"SR Nazarie Ignat","year":"2021","unstructured":"Nazarie Ignat SR, Gharbia S, Hermenean A, Dinescu S, Costache M. Regenerative potential of mesenchymal stem cells\u2019 (MSCs) secretome for liver fibrosis therapies. Int J Mol Sci. 2021;22:13292.","journal-title":"Int J Mol Sci"},{"key":"631_CR8","doi-asserted-by":"publisher","first-page":"594794","DOI":"10.3389\/fcell.2020.594794","volume":"8","author":"G Chiabotto","year":"2020","unstructured":"Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular pathways modulated by mesenchymal stromal cells and their extracellular vesicles in experimental models of liver fibrosis. Front Cell Dev Biol. 2020;8:594794.","journal-title":"Front Cell Dev Biol"},{"key":"631_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-022-02906-z","volume":"13","author":"QW Liu","year":"2022","unstructured":"Liu QW, Ying YM, Zhou JX, Zhang WJ, Liu ZX, Jia BB, et al. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/beta-catenin signaling pathway in mice. Stem Cell Res Ther. 2022;13:224.","journal-title":"Stem Cell Res Ther"},{"key":"631_CR10","doi-asserted-by":"publisher","first-page":"3212643","DOI":"10.1155\/2018\/3212643","volume":"2018","author":"M Ohara","year":"2018","unstructured":"Ohara M, Ohnishi S, Hosono H, Yamamoto K, Yuyama K, Nakamura H, et al. Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats. Stem Cells Int. 2018;2018:3212643.","journal-title":"Stem Cells Int"},{"key":"631_CR11","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21:2491\u2013502.","journal-title":"J Cell Mol Med"},{"key":"631_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","volume":"7","author":"Y Cai","year":"2009","unstructured":"Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genom Proteom Bioinform. 2009;7:147\u201354.","journal-title":"Genom Proteom Bioinform"},{"key":"631_CR13","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1002\/jcb.27746","volume":"120","author":"F Ji","year":"2019","unstructured":"Ji F, Wang K, Zhang Y, Mao XL, Huang Q, Wang J, et al. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7. J Cell Biochem. 2019;120:4573\u201381.","journal-title":"J Cell Biochem"},{"key":"631_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2018.04.016","volume":"12","author":"K You","year":"2018","unstructured":"You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, et al. MicroRNA-125b promotes hepatic stellate cell activation and liver fibrosis by activating RhoA signaling. Mol Ther Nucleic Acids. 2018;12:57\u201366.","journal-title":"Mol Ther Nucleic Acids"},{"key":"631_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biom12060781","volume":"12","author":"V Sundararajan","year":"2022","unstructured":"Sundararajan V, Burk UC, Bajdak-Rusinek K. Revisiting the miR-200 family: a clan of five siblings with essential roles in development and disease. Biomolecules. 2022;12:781.","journal-title":"Biomolecules"},{"key":"631_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.cellsig.2014.01.003","volume":"26","author":"Y Xiao","year":"2014","unstructured":"Xiao Y, Wang J, Chen Y, Zhou K, Wen J, Wang Y, et al. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K\/Akt signaling. Cell Signal. 2014;26:925\u201332.","journal-title":"Cell Signal"},{"key":"631_CR17","doi-asserted-by":"publisher","first-page":"2670658","DOI":"10.1155\/2017\/2670658","volume":"2017","author":"T Ma","year":"2017","unstructured":"Ma T, Cai X, Wang Z, Huang L, Wang C, Jiang S, et al. miR-200c accelerates hepatic stellate cell-induced liver fibrosis via targeting the FOG2\/PI3K pathway. Biomed Res Int. 2017;2017:2670658.","journal-title":"Biomed Res Int"},{"key":"631_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00011-016-1020-4","volume":"66","author":"JJ Yang","year":"2017","unstructured":"Yang JJ, Tao H, Liu LP, Hu W, Deng ZY, Li J. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1\/Notch1 signal pathway. Inflamm Res. 2017;66:341\u201352.","journal-title":"Inflamm Res"},{"key":"631_CR19","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1002\/jcp.30177","volume":"236","author":"H Li","year":"2021","unstructured":"Li H, Zou J, Yu XH, Ou X, Tang CK. Zinc finger E-box binding homeobox 1 and atherosclerosis: new insights and therapeutic potential. J Cell Physiol. 2021;236:4216\u201330.","journal-title":"J Cell Physiol"},{"key":"631_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu H, Zhao J, Li J, Zhu Z, Cui Z, Liu R, et al. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1alpha\/ZEB1 axis. Cell Death Dis. 2022;13:478.","journal-title":"Cell Death Dis"},{"key":"631_CR21","doi-asserted-by":"publisher","first-page":"13196","DOI":"10.1111\/jcmm.15929","volume":"24","author":"R Zhou","year":"2020","unstructured":"Zhou R, Li S, Mei X, Jiang T, Wang Q. Remifentanil up-regulates HIF1alpha expression to ameliorate hepatic ischaemia\/reperfusion injury via the ZEB1\/LIF axis. J Cell Mol Med. 2020;24:13196\u2013207.","journal-title":"J Cell Mol Med"},{"key":"631_CR22","doi-asserted-by":"publisher","first-page":"172787","DOI":"10.1016\/j.ejphar.2019.172787","volume":"865","author":"LY Li","year":"2019","unstructured":"Li LY, Yang CC, Yang JF, Li HD, Zhang BY, Zhou H, et al. ZEB1 regulates the activation of hepatic stellate cells through Wnt\/beta-catenin signaling pathway. Eur J Pharmacol. 2019;865:172787.","journal-title":"Eur J Pharmacol"},{"key":"631_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/1744666X.2021.1945443","volume":"17","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Deenick EK, Tangye SG. Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications. Expert Rev Clin Immunol. 2021;17:905\u201314.","journal-title":"Expert Rev Clin Immunol"},{"key":"631_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X, Yang B, He Q, Wang J, et al. Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 2022;12:18\u201332.","journal-title":"Acta Pharm Sin B"},{"key":"631_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbrc.2020.06.102","volume":"529","author":"J Fu","year":"2020","unstructured":"Fu J, Wu B, Zhong S, Deng W, Lin F. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression. Biochem Biophys Res Commun. 2020;529:922\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"631_CR26","unstructured":"Institute of Laboratory Animal Resources (US) In: Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC); 2011."},{"key":"631_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2020.00054","volume":"11","author":"M Bulati","year":"2020","unstructured":"Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, et al. the immunomodulatory properties of the human amnion-derived mesenchymal stromal\/stem cells are induced by INF-gamma produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Front Immunol. 2020;11:54.","journal-title":"Front Immunol"},{"key":"631_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcmm.16119","volume":"25","author":"Z Du","year":"2021","unstructured":"Du Z, Wu T, Liu L, Luo B, Wei C. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis. J Cell Mol Med. 2021;25:701\u201315.","journal-title":"J Cell Mol Med"},{"key":"631_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696\u20139.","journal-title":"J Hepatol"},{"key":"631_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2017.09.027","volume":"636","author":"W Chen","year":"2017","unstructured":"Chen W, Zhao W, Yang A, Xu A, Wang H, Cong M, et al. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis. Gene. 2017;636:87\u201395.","journal-title":"Gene"},{"key":"631_CR31","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","journal-title":"Elife"},{"key":"631_CR32","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13:e0206239.","journal-title":"PLoS ONE"},{"key":"631_CR33","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"631_CR34","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48:D148\u201354.","journal-title":"Nucleic Acids Res"},{"key":"631_CR35","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50:D165\u201373.","journal-title":"Nucleic Acids Res"},{"key":"631_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.023","volume":"28","author":"H Ding","year":"2019","unstructured":"Ding H, Gao S, Wang L, Wei Y, Zhang M. Overexpression of miR-582-5p inhibits the apoptosis of neuronal cells after cerebral ischemic stroke through regulating PAR-1\/Rho\/Rho axis. J Stroke Cerebrovasc Dis. 2019;28:149\u201355.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"631_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"631_CR38","first-page":"1861","volume":"21","author":"L Li","year":"2020","unstructured":"Li L, Ran J, Li L, Chen G, Zhang S, Wang Y. Gli3 is a novel downstream target of miR-200a with an anti- fi brotic role for progression of liver fibrosis in vivo and in vitro. Mol Med Rep. 2020;21:1861\u201371.","journal-title":"Mol Med Rep"},{"key":"631_CR39","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.3892\/mmr.2015.4452","volume":"12","author":"F Yu","year":"2015","unstructured":"Yu F, Zheng Y, Hong W, Chen B, Dong P, Zheng J. MicroRNA-200a suppresses epithelial-to-mesenchymal transition in rat hepatic stellate cells via GLI family zinc finger 2. Mol Med Rep. 2015;12:8121\u20138.","journal-title":"Mol Med Rep"},{"key":"631_CR40","doi-asserted-by":"publisher","first-page":"172927","DOI":"10.1016\/j.ejphar.2020.172927","volume":"871","author":"J Yang","year":"2020","unstructured":"Yang J, Tao Q, Zhou Y, Chen Q, Li L, Hu S, et al. MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt\/beta-catenin pathway. Eur J Pharmacol. 2020;871:172927.","journal-title":"Eur J Pharmacol"},{"key":"631_CR41","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62:S15-24.","journal-title":"J Hepatol"},{"key":"631_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8:1605.","journal-title":"Cells"},{"key":"631_CR43","doi-asserted-by":"publisher","first-page":"833878","DOI":"10.3389\/fimmu.2022.833878","volume":"13","author":"R Wu","year":"2022","unstructured":"Wu R, Fan X, Wang Y, Shen M, Zheng Y, Zhao S, et al. Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy. Front Immunol. 2022;13:833878.","journal-title":"Front Immunol"},{"key":"631_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","volume":"13","author":"F Lin","year":"2022","unstructured":"Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13:271.","journal-title":"Cell Death Dis"},{"key":"631_CR45","first-page":"249","volume":"30","author":"QM Luo","year":"2022","unstructured":"Luo QM, Zhu S, Peng L. Gao ZL [Research advances in the treatment of liver failure with mesenchymal stem cell-derived exosomes]. Zhonghua Gan Zang Bing Za Zhi. 2022;30:249\u201352.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"631_CR46","doi-asserted-by":"publisher","first-page":"e128060","DOI":"10.1172\/jci.insight.128060","volume":"4","author":"N Mansouri","year":"2019","unstructured":"Mansouri N, Willis GR, Fernandez-Gonzalez A, Reis M, Nassiri S, Mitsialis SA, et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. JCI Insight. 2019;4:e128060.","journal-title":"JCI Insight"},{"key":"631_CR47","doi-asserted-by":"publisher","first-page":"9425","DOI":"10.7150\/thno.43315","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Wang Y, Li S, Zuo B, Zhang X, Wang F, et al. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1\/eNOS signaling pathway. Theranostics. 2020;10:9425\u201342.","journal-title":"Theranostics"},{"key":"631_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/beta-catenin pathway. Stem Cell Res Ther. 2019;10:98.","journal-title":"Stem Cell Res Ther"},{"key":"631_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","volume":"13","author":"S Tian","year":"2022","unstructured":"Tian S, Zhou X, Zhang M, Cui L, Li B, Liu Y, et al. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages. Stem Cell Res Ther. 2022;13:330.","journal-title":"Stem Cell Res Ther"},{"key":"631_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12951-022-01636-x","volume":"20","author":"Y Lin","year":"2022","unstructured":"Lin Y, Yan M, Bai Z, Xie Y, Ren L, Wei J, et al. Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnology. 2022;20:432.","journal-title":"J Nanobiotechnology"},{"key":"631_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08666-0","author":"SS Tamber","year":"2023","unstructured":"Tamber SS, Bansal P, Sharma S, Singh RB, Sharma R. Biomarkers of liver diseases. Mol Biol Rep. 2023;50:7815\u201323.","journal-title":"Mol Biol Rep"},{"key":"631_CR52","doi-asserted-by":"publisher","first-page":"153294","DOI":"10.1016\/j.phymed.2020.153294","volume":"78","author":"D Xiang","year":"2020","unstructured":"Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, et al. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-beta\/Smad and YAP signaling. Phytomedicine. 2020;78:153294.","journal-title":"Phytomedicine"},{"key":"631_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui AY, Albanis E, Arthur MJ, O\u2019Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54:142\u201351.","journal-title":"Gut"},{"key":"631_CR54","doi-asserted-by":"publisher","first-page":"36436","DOI":"10.1038\/srep36436","volume":"6","author":"BL Hu","year":"2016","unstructured":"Hu BL, Shi C, Lei RE, Lu DH, Luo W, Qin SY, et al. Interleukin-22 ameliorates liver fibrosis through miR-200a\/beta-catenin. Sci Rep. 2016;6:36436.","journal-title":"Sci Rep"},{"key":"631_CR55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajpath.2011.10.005","volume":"180","author":"S Yang","year":"2012","unstructured":"Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180:484\u201393.","journal-title":"Am J Pathol"},{"key":"631_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-017-2988-y","volume":"431","author":"M Xu","year":"2017","unstructured":"Xu M, Wang G, Zhou H, Cai J, Li P, Zhou M, et al. TGF-beta1-miR-200a-PTEN induces epithelial-mesenchymal transition and fibrosis of pancreatic stellate cells. Mol Cell Biochem. 2017;431:161\u20138.","journal-title":"Mol Cell Biochem"},{"key":"631_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2023.05.005","author":"X Liu","year":"2023","unstructured":"Liu X, Liu G, Tan Y, Liu P, Li L. Upregulation of miR-200a improves ureteral obstruction-induced renal fibrosis via GAB1\/Wnt\/beta-catenin signaling. Nefrologia (Engl Ed). 2023:43:21\u201331.","journal-title":"Nefrologia (Engl Ed)"},{"key":"631_CR58","first-page":"3863","volume":"24","author":"Q Pan","year":"2014","unstructured":"Pan Q, Guo C, Sun C, Fan J, Fang C. Integrative analysis of the transcriptome and targetome identifies the regulatory network of miR-16: an inhibitory role against the activation of hepatic stellate cells. Biomed Mater Eng. 2014;24:3863\u201371.","journal-title":"Biomed Mater Eng"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-024-00631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-024-00631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-024-00631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T17:14:01Z","timestamp":1715361241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-024-00631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s13770-024-00631-7","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There are no animal experiments carried out for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}